CoChat

TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer’s disease

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Background: Amyloid plaques, a pathological hallmark of Alzheimer's disease (AD), are accompanied by activated microglia. The role of activated microglia in the pathogenesis of AD remains controversial: either clearing Aβ deposits by phagocytosis or releasing proinflammatory cytokines and cytotoxic substances. Microglia can be activated via toll-like receptors (TLRs), a class of pattern-recognition receptors in the innate immune system. We previously demonstrated that an AD mouse model homozygous for a loss-of-function mutation of TLR4 had increases in Aβ deposits and buffer-soluble Aβ in the brain as compared with a TLR4 wild-type AD mouse model at 14-16 months of age. However, it is unknown if TLR4 signaling is involved in initiation of Aβ deposition as well as activation and recruitment of microglia at the early stage of AD. Here, we investigated the role of TLR4 signaling and microglial activation in early stages using 5-month-old AD mouse models when Aβ deposits start. Methods: Microglial activation and amyloid deposition in the brain were determined by immunohistochemistry in the AD models. Levels of cerebral soluble Aβ were determined by ELISA. mRNA levels of cytokines and chemokines in the brain and Aβ-stimulated monocytes were quantified by real-time PCR. Cognitive functions were assessed by the Morris water maze. Results: While no difference was found in cerebral Aβ load between AD mouse models at 5 months with and without TLR4 mutation, microglial activation in a TLR4 mutant AD model (TLR4M Tg) was less than that in a TLR4 wild-type AD model (TLR4W Tg). At 9 months, TLR4M Tg mice had increased Aβ deposition and soluble Aβ42 in the brain, which were associated with decrements in cognitive functions and expression levels of IL-1β, CCL3, and CCL4 in the hippocampus compared to TLR4W Tg mice. TLR4 mutation diminished Aβ-induced IL-1β, CCL3, and CCL4 expression in monocytes. Conclusion: This is the first demonstration of TLR4-dependent activation of microglia at the early stage of β-amyloidosis. Our results indicate that TLR4 is not involved in the initiation of Aβ deposition and that, as Aβ deposits start, microglia are activated via TLR4 signaling to reduce Aβ deposits and preserve cognitive functions from Aβ-mediated neurotoxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-8-92

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 TLR4 mutation did not influence Aβ load but diminished microglial activation in an AD mouse model at 5 months of age. Aβ deposits in the brains of TLR4W Tg (A) and TLR4M Tg (B) mice were visualized by anti-Aβ antibody (6E10). Activated microglia are visualized by anti-CD11b antibody in TLR4W Tg (C) and TLR4M Tg (D) mice. The inset image (C) is a higher magnification of the area indicated by the square. (E) Cerebral Aβ plaques are visualized by 6E10 and average percentages of Aβ-immunoreactive areas in the cerebral cortex are shown as a bar graph (means ± SEM). Average percentages of immunoreactive areas in the cerebral cortex for an activated microglial marker, CD11b (F), are shown as a bar graph (means ± SEM). The ratio of CD11b-immunoreactive area to 6E10-immunoreactive area in the cerebral cortex (G) are shown as a bar graph (means ± SEM). Brain sections from 5-month-old TLR4W Tg (H) and TLR4M Tg (I) mice were subjected to double-label fluorescence immunohistochemistry using anti-CD11b (green) antibody and 6E10 (red). *P ≤ 0.05. Scale bars 200 μm for A through D, 50 μm for H and I, and 10 μm for the inset.
Figure 1 TLR4 mutation did not influence Aβ load but diminished microglial activation in an AD mouse model at 5 months of age. Aβ deposits in the brains of TLR4W Tg (A) and TLR4M Tg (B) mice were visualized by anti-Aβ antibody (6E10). Activated microglia are visualized by anti-CD11b antibody in TLR4W Tg (C) and TLR4M Tg (D) mice. The inset image (C) is a higher magnification of the area indicated by the square. (E) Cerebral Aβ plaques are visualized by 6E10 and average percentages of Aβ-immunoreactive areas in the cerebral cortex are shown as a bar graph (means ± SEM). Average percentages of immunoreactive areas in the cerebral cortex for an activated microglial marker, CD11b (F), are shown as a bar graph (means ± SEM). The ratio of CD11b-immunoreactive area to 6E10-immunoreactive area in the cerebral cortex (G) are shown as a bar graph (means ± SEM). Brain sections from 5-month-old TLR4W Tg (H) and TLR4M Tg (I) mice were subjected to double-label fluorescence immunohistochemistry using anti-CD11b (green) antibody and 6E10 (red). *P ≤ 0.05. Scale bars 200 μm for A through D, 50 μm for H and I, and 10 μm for the inset.CC BY · PubMed Central
Figure 2 TLR4 mutation increased Aβ load in the brain of an AD mouse model at 9 months of age. Aβ plaques in the brains of TLR4W Tg (A and C) and TLR4M Tg (B and D) mice were visualized by 6E10 immunohistochemistry and thioflavin S fluorescence, respectively. Average percentages of areas showing Aβ immunoreactivity and fluorescence in the neocortex (G and I) and hippocampus (H and J) are shown as a bar graph (means ± SEM). Activated microglia were detected by anti-CD11b antibody in TLR4W Tg (E) and TLR4M Tg (F) mice. The inset images (E and F) are a higher magnification of the areas indicated by the squares. Average percentages of CD11b-immunoreactive areas in the neocortex (K) and hippocampus (L) are shown as a bar graph (means ± SEM). The ratio of CD11b-immunoreactive area to 6E10-immunoreactive area in the neocortex (M) and hippocampus (N) are shown as a bar graph (means ± SEM). *P < 0.05. Scale bars 200 μm for A through F and 10 μm for the insets.
Figure 2 TLR4 mutation increased Aβ load in the brain of an AD mouse model at 9 months of age. Aβ plaques in the brains of TLR4W Tg (A and C) and TLR4M Tg (B and D) mice were visualized by 6E10 immunohistochemistry and thioflavin S fluorescence, respectively. Average percentages of areas showing Aβ immunoreactivity and fluorescence in the neocortex (G and I) and hippocampus (H and J) are shown as a bar graph (means ± SEM). Activated microglia were detected by anti-CD11b antibody in TLR4W Tg (E) and TLR4M Tg (F) mice. The inset images (E and F) are a higher magnification of the areas indicated by the squares. Average percentages of CD11b-immunoreactive areas in the neocortex (K) and hippocampus (L) are shown as a bar graph (means ± SEM). The ratio of CD11b-immunoreactive area to 6E10-immunoreactive area in the neocortex (M) and hippocampus (N) are shown as a bar graph (means ± SEM). *P < 0.05. Scale bars 200 μm for A through F and 10 μm for the insets.CC BY · PubMed Central
Figure 3 TLR4 mutation increased cerebral buffer-soluble Aβ42 in an AD mouse model at 9 months of age. The cerebral buffer-soluble Aβ42 and Aβ40 contents in TLR4W and TLR4M Tg mice were quantified by ELISA. The results are shown as bar graphs (means ± SEM pg/mg total protein). *P < 0.01.
Figure 3 TLR4 mutation increased cerebral buffer-soluble Aβ42 in an AD mouse model at 9 months of age. The cerebral buffer-soluble Aβ42 and Aβ40 contents in TLR4W and TLR4M Tg mice were quantified by ELISA. The results are shown as bar graphs (means ± SEM pg/mg total protein). *P < 0.01.CC BY · PubMed Central
Figure 4 Aβ plaques were surrounded by activated microglia expressing TLR4. A brain section from a TLR4W Tg mouse was stained with thioflavin S for fibrillar amyloid deposits (B) and immunostained with anti-CD11b antibody using avidin-biotin immuno-peroxidase method and DAB (A). (C) is a superimposition of (A) and (B), demonstrating that fibrillar Aβ deposits are closely accompanied by CD11b-positive microglia. Brain sections from a TLR4W Tg mouse were labeled with anti-TLR4 antibody (green) (E and H) followed by staining with anti-CD11b (red) (D) or anti-CD45 (red) (G) antibody. The yellow colors in the superimposed images of (F) and (I) between (D) and (E) and between (G) and (H) indicate co-localization of TLR4 with activated microglia (CD11b and CD45), respectively. Overlap between astrocytes detected by anti-GFAP antibody (red) (J) and TLR4 (green) (K) is occasionally found in the merged picture (L). Scale bars 50 μm.Asterisks indicate amyloid plaques.
Figure 4 Aβ plaques were surrounded by activated microglia expressing TLR4. A brain section from a TLR4W Tg mouse was stained with thioflavin S for fibrillar amyloid deposits (B) and immunostained with anti-CD11b antibody using avidin-biotin immuno-peroxidase method and DAB (A). (C) is a superimposition of (A) and (B), demonstrating that fibrillar Aβ deposits are closely accompanied by CD11b-positive microglia. Brain sections from a TLR4W Tg mouse were labeled with anti-TLR4 antibody (green) (E and H) followed by staining with anti-CD11b (red) (D) or anti-CD45 (red) (G) antibody. The yellow colors in the superimposed images of (F) and (I) between (D) and (E) and between (G) and (H) indicate co-localization of TLR4 with activated microglia (CD11b and CD45), respectively. Overlap between astrocytes detected by anti-GFAP antibody (red) (J) and TLR4 (green) (K) is occasionally found in the merged picture (L). Scale bars 50 μm.Asterisks indicate amyloid plaques.CC BY · PubMed Central
Figure 5 An AD mouse model with TLR4 mutation was more vulnerable to cognitive impairment as assessed in the Morris water maze. Total cumulated scores per day for escape latencies (sec) (A) and path length (cm) (B) (means ± SEM) are shown during acquisition of the hidden platform task at 9 months of age. Spatial learning was impaired in TLR4M Tg mice as shown by increases in escape latencies and path length (*P < 0.05; **P < 0.01). No difference was found between any other groups.
Figure 5 An AD mouse model with TLR4 mutation was more vulnerable to cognitive impairment as assessed in the Morris water maze. Total cumulated scores per day for escape latencies (sec) (A) and path length (cm) (B) (means ± SEM) are shown during acquisition of the hidden platform task at 9 months of age. Spatial learning was impaired in TLR4M Tg mice as shown by increases in escape latencies and path length (*P < 0.05; **P < 0.01). No difference was found between any other groups.CC BY · PubMed Central
Figure 6 TLR4 mutation decreased expression levels of IL-1β, CCL3 and CCL4 in an AD mouse model at 9 months of age. mRNA levels of cytokines and chemokines in the neocortex and hippocampus from TLR4W and TLR4M Tg mice at age 5 and 9 months were determined by real-time PCR using cDNA prepared by reverse-transcription of mRNA. mRNA levels of cytokines and chemokines were normalized by subtracting cycle threshold (Ct) values obtained with GAPDH mRNA and are shown as 2 -ΔCt [ΔCt = Ct (cytokine or chemokine) - Ct (GAPDH)] (means ± SEM). *P < 0.05.
Figure 6 TLR4 mutation decreased expression levels of IL-1β, CCL3 and CCL4 in an AD mouse model at 9 months of age. mRNA levels of cytokines and chemokines in the neocortex and hippocampus from TLR4W and TLR4M Tg mice at age 5 and 9 months were determined by real-time PCR using cDNA prepared by reverse-transcription of mRNA. mRNA levels of cytokines and chemokines were normalized by subtracting cycle threshold (Ct) values obtained with GAPDH mRNA and are shown as 2 -ΔCt [ΔCt = Ct (cytokine or chemokine) - Ct (GAPDH)] (means ± SEM). *P < 0.05.CC BY · PubMed Central
Figure 7 TLR4M monocytes express less IL-1α, IL-1β, IL-6, CCL3 and CCL4 than TLR4W monocytes after fibrillar Aβ stimulation. CD11b+ splenocytes (monocytes) from 2-month-old TLR4W and TLR4 M Tg mice were collected by FACS. After treatment with fibrillar Aβ for 4 hours, mRNA levels of cytokines and chemokines were determined by real-time PCR. mRNA levels of cytokines and chemokines were normalized by subtracting cycle threshold (Ct) values obtained with GAPDH mRNA and are shown as 2 -ΔCt [ΔCt = Ct (cytokine or chemokine) - Ct (GAPDH)] (means ± SEM). *P < 0.005.
Figure 7 TLR4M monocytes express less IL-1α, IL-1β, IL-6, CCL3 and CCL4 than TLR4W monocytes after fibrillar Aβ stimulation. CD11b+ splenocytes (monocytes) from 2-month-old TLR4W and TLR4 M Tg mice were collected by FACS. After treatment with fibrillar Aβ for 4 hours, mRNA levels of cytokines and chemokines were determined by real-time PCR. mRNA levels of cytokines and chemokines were normalized by subtracting cycle threshold (Ct) values obtained with GAPDH mRNA and are shown as 2 -ΔCt [ΔCt = Ct (cytokine or chemokine) - Ct (GAPDH)] (means ± SEM). *P < 0.005.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 38 references

Cited by

See all 273

Metadata

Authors
Song, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I.
Affiliations
  • Peoria campus of the University of Illinois System (US)
  • New York Medical College (US)
  • Université de Rouen Normandie (FR)
Corresponding author
Fukuchi, Ken-ichiro
Venue
Journal of Neuroinflammation
Published
2011-08-09
Volume
8
Issue
1
Pages
92-92
ISSN
1742-2094 (ISSN-L)
OpenAlex
W1970347605
Cited by
273
References
38
Citations by year
2026: 11 · 2025: 14 · 2024: 19 · 2023: 12 · 2022: 19 · 2021: 25 · 2020: 24 · 2019: 28 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 20 · 2014: 19 · 2013: 25 · 2012: 15
FWCI
10.44
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Touro Scholar (Touro College) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Alzheimer's Association (EY018478, IIRG-07-59494, AG029818, AG030399, AG031979)
  • National Institutes of Health (AG029818, IIRG-07-59494)
  • National Institute on Aging (R21AG031979, R01AG030399, AG031979, AG029818, AG030399, R21AG029818)
  • National Eye Institute (EY018478, R21EY018478)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
TLR4, microglial activation, Alzheimer's disease, amyloid-beta deposition, IL-1β, CCL3, carbon tetrachloride, chemokines, monocytes, cognitive impairment, Tg2576 mice, innate immunity, hippocampus, neuroinflammation
MeSH terms
Alzheimer Disease, Animals, Behavior, Animal, Brain, Cognition Disorders, Disease Models, Animal, Humans, Mice, Transgenic, Mutation, Signal Transduction, Cytokines, Amyloid beta-Protein Precursor, Microglia, Maze Learning, Chemokines, Toll-Like Receptor 4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer’s disease. https://app.cochat.ai/papers/10.1186/1742-2094-8-92
The paper
Song, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I. (2011). TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer’s disease. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-8-92

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.